100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Auxigin 150 SR Tablet
Alniche Life Sciences Pvt. Ltd.
₹65
Our Recommendation
Xbaren 150mg Tablet SR 10s
328+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Epilepsy/Seizures
Customers also bought
More About Auxigin 150 SR Tablet
Benefits
In Epilepsy/Seizures Auxigin 150 SR Tablet is an anticonvulsant (or anti-epileptic) medicine that works by decreasing the nerve impulses which cause the seizures. By controlling the frequency of seizures, it will help you go about your daily activities with more confidence. It helps reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. This medicine is not associated with any physical or psychological dependence (addiction) but it should not be stopped suddenly. It must be taken regularly as prescribed to be effective. Missing doses may trigger a seizure.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Auxigin 150 SR Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Auxigin 150 SR Tablet is an antiepileptic medication. It controls seizures or fits by decreasing the abnormal and excessive activity of the nerve cells in the brain.
Unsafe: Avoid consuming alcohol with Auxigin 150 SR Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Auxigin 150 SR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Auxigin 150 SR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Baby should be monitored for excessive sleepiness and weight gain.
Not Safe: Auxigin 150 SR Tablet may cause side effects which could affect your ability to drive. Auxigin 150 SR Tablet may make you feel sleepy or dizzy, or may cause blurred vision, lack of muscle coordination, especially when starting treatment or increasing the dose. This may affect your driving ability.
Caution Advised: Auxigin 150 SR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Auxigin 150 SR Tablet may be needed. Doctor consultation is advised.
Caution Advised: Auxigin 150 SR Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Auxigin 150 SR Tablet may be needed. Doctor consultation is advised. Dose adjustment is not recommended in patients with mild to moderate liver disease.
What if I forget to take it?
If a dose of Auxigin 150 SR Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi ‚ 110 027
References
Stahl SM, editor. Oxcarbazepine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 497-501
Porters RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 406-407
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1037-38
Oxcarbazepine. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2000 (22 Jan. 2019)
Oxcarbazepine. Dublin 13, Ireland: Gerard Laboratories; 2018 (17 Jun. 2019)
Oxcarbazine. Mumbai, India: Sun Pharmaceutical Industries Ltd.; 2007 (25 Mar 2019)
Oxcarbazepine. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2000 (17 Jun. 2019)
Oxcarbazepine. Macquarie Park, New South Wales: Novartis Pharmaceuticals Australia Pty Limited; 2017 (17 Jun. 2019)
Drugs and Lactation Database (LactMed) (20 Feb. 2020)
Drugs.com. Oxcarbazepine (25 Mar 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
